Skip to main content

The Current Molecular Treatment Landscape of Advanced Colorectal Cancer and Need for the COLOMATE Platform.

Publication ,  Journal Article
Ciombor, K; Jones, J; Strickler, J; Bekaii-Saab, T; Wu, C
Published in: Oncology (Williston Park)
September 15, 2021

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Oncology (Williston Park)

DOI

ISSN

0890-9091

Publication Date

September 15, 2021

Volume

35

Issue

9

Start / End Page

553 / 559

Location

United States

Related Subject Headings

  • Receptor, erbB-2
  • Receptor, ErbB-2
  • Proto-Oncogene Proteins p21(ras)
  • Neoplastic Syndromes, Hereditary
  • Mutation
  • Microsatellite Instability
  • Liquid Biopsy
  • Humans
  • High-Throughput Nucleotide Sequencing
  • ErbB Receptors
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ciombor, K., Jones, J., Strickler, J., Bekaii-Saab, T., & Wu, C. (2021). The Current Molecular Treatment Landscape of Advanced Colorectal Cancer and Need for the COLOMATE Platform. Oncology (Williston Park), 35(9), 553–559. https://doi.org/10.46883/ONC.2021.3509.0553
Ciombor, Kristen, Jeremy Jones, John Strickler, Tanios Bekaii-Saab, and Christina Wu. “The Current Molecular Treatment Landscape of Advanced Colorectal Cancer and Need for the COLOMATE Platform.Oncology (Williston Park) 35, no. 9 (September 15, 2021): 553–59. https://doi.org/10.46883/ONC.2021.3509.0553.
Ciombor K, Jones J, Strickler J, Bekaii-Saab T, Wu C. The Current Molecular Treatment Landscape of Advanced Colorectal Cancer and Need for the COLOMATE Platform. Oncology (Williston Park). 2021 Sep 15;35(9):553–9.
Ciombor, Kristen, et al. “The Current Molecular Treatment Landscape of Advanced Colorectal Cancer and Need for the COLOMATE Platform.Oncology (Williston Park), vol. 35, no. 9, Sept. 2021, pp. 553–59. Pubmed, doi:10.46883/ONC.2021.3509.0553.
Ciombor K, Jones J, Strickler J, Bekaii-Saab T, Wu C. The Current Molecular Treatment Landscape of Advanced Colorectal Cancer and Need for the COLOMATE Platform. Oncology (Williston Park). 2021 Sep 15;35(9):553–559.

Published In

Oncology (Williston Park)

DOI

ISSN

0890-9091

Publication Date

September 15, 2021

Volume

35

Issue

9

Start / End Page

553 / 559

Location

United States

Related Subject Headings

  • Receptor, erbB-2
  • Receptor, ErbB-2
  • Proto-Oncogene Proteins p21(ras)
  • Neoplastic Syndromes, Hereditary
  • Mutation
  • Microsatellite Instability
  • Liquid Biopsy
  • Humans
  • High-Throughput Nucleotide Sequencing
  • ErbB Receptors